Pre-order Enquiry
Request Free Sample
Global Nuclear Medicine/Radiopharmaceutic Market Insights, Forecast to 2025
SKU ID : QYR-14117156 | Publishing Date : 18-Apr-2019 | No. of pages : 123
Detailed TOC of Global Nuclear Medicine/Radiopharmaceutic Market Insights, Forecast to 2025
Table of Contents1 Study Coverage
1.1 Nuclear Medicine/Radiopharmaceutic Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Product
1.4.2 Diagnostic
1.4.3 Therapeutic
1.5 Market by End User
1.5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by End User
1.5.2 Oncology
1.5.3 Thyroid
1.5.4 Cardiology
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size
2.1.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2014-2025
2.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2014-2025
2.2 Nuclear Medicine/Radiopharmaceutic Growth Rate by Regions
2.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Regions
2.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers
3.1.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers
3.1.2 Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers
3.1.3 Global Nuclear Medicine/Radiopharmaceutic Market Concentration Ratio (CR5 and HHI)
3.2 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers
3.2.1 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2014-2019)
3.2.2 Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2014-2019)
3.3 Nuclear Medicine/Radiopharmaceutic Price by Manufacturers
3.4 Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Product
4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Product
4.3 Nuclear Medicine/Radiopharmaceutic Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Nuclear Medicine/Radiopharmaceutic Breakdown Data by End User
6 North America
6.1 North America Nuclear Medicine/Radiopharmaceutic by Countries
6.1.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Countries
6.1.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Nuclear Medicine/Radiopharmaceutic by Product
6.3 North America Nuclear Medicine/Radiopharmaceutic by End User
7 Europe
7.1 Europe Nuclear Medicine/Radiopharmaceutic by Countries
7.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Countries
7.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nuclear Medicine/Radiopharmaceutic by Product
7.3 Europe Nuclear Medicine/Radiopharmaceutic by End User
8 Asia Pacific
8.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Countries
8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Countries
8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Product
8.3 Asia Pacific Nuclear Medicine/Radiopharmaceutic by End User
9 Central & South America
9.1 Central & South America Nuclear Medicine/Radiopharmaceutic by Countries
9.1.1 Central & South America Nuclear Medicine/Radiopharmaceutic Sales by Countries
9.1.2 Central & South America Nuclear Medicine/Radiopharmaceutic Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Nuclear Medicine/Radiopharmaceutic by Product
9.3 Central & South America Nuclear Medicine/Radiopharmaceutic by End User
10 Middle East and Africa
10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Countries
10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Countries
10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Product
10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by End User
11 Company Profiles
11.1 China Isotope Radiation
11.1.1 China Isotope Radiation Company Details
11.1.2 Company Business Overview
11.1.3 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
11.1.4 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Products Offered
11.1.5 China Isotope Radiation Recent Development
11.2 Dongcheng
11.2.1 Dongcheng Company Details
11.2.2 Company Business Overview
11.2.3 Dongcheng Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Dongcheng Nuclear Medicine/Radiopharmaceutic Products Offered
11.2.5 Dongcheng Recent Development
11.3 Jaco
11.3.1 Jaco Company Details
11.3.2 Company Business Overview
11.3.3 Jaco Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Jaco Nuclear Medicine/Radiopharmaceutic Products Offered
11.3.5 Jaco Recent Development
11.4 Ciaeriar
11.4.1 Ciaeriar Company Details
11.4.2 Company Business Overview
11.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceutic Products Offered
11.4.5 Ciaeriar Recent Development
11.5 Advanced Molecular-imaging Solution
11.5.1 Advanced Molecular-imaging Solution Company Details
11.5.2 Company Business Overview
11.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Products Offered
11.5.5 Advanced Molecular-imaging Solution Recent Development
11.6 Shanghai Atom Kexing
11.6.1 Shanghai Atom Kexing Company Details
11.6.2 Company Business Overview
11.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Products Offered
11.6.5 Shanghai Atom Kexing Recent Development
11.7 Cardinal Health
11.7.1 Cardinal Health Company Details
11.7.2 Company Business Overview
11.7.3 Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Cardinal Health Nuclear Medicine/Radiopharmaceutic Products Offered
11.7.5 Cardinal Health Recent Development
11.8 Mallinckrodt
11.8.1 Mallinckrodt Company Details
11.8.2 Company Business Overview
11.8.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Products Offered
11.8.5 Mallinckrodt Recent Development
11.9 GE Healthcare
11.9.1 GE Healthcare Company Details
11.9.2 Company Business Overview
11.9.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
11.9.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
11.9.5 GE Healthcare Recent Development
11.10 Lantheus Medical Imaging
11.10.1 Lantheus Medical Imaging Company Details
11.10.2 Company Business Overview
11.10.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
11.10.5 Lantheus Medical Imaging Recent Development
11.11 Bayer Healthcare
11.12 Bracco Imaging
11.13 Eczacibasi-Monrol Nuclear Products
11.14 Nordion
11.15 Advanced Accelerator Applications
11.16 Iba Molecular Imaging
12 Future Forecast
12.1 Nuclear Medicine/Radiopharmaceutic Market Forecast by Regions
12.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions 2019-2025
12.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions 2019-2025
12.2 Nuclear Medicine/Radiopharmaceutic Market Forecast by Product
12.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Product 2019-2025
12.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Product 2019-2025
12.3 Nuclear Medicine/Radiopharmaceutic Market Forecast by End User
12.4 North America Nuclear Medicine/Radiopharmaceutic Forecast
12.5 Europe Nuclear Medicine/Radiopharmaceutic Forecast
12.6 Asia Pacific Nuclear Medicine/Radiopharmaceutic Forecast
12.7 Central & South America Nuclear Medicine/Radiopharmaceutic Forecast
12.8 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nuclear Medicine/Radiopharmaceutic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global Nuclear Medicine/Radiopharmaceutic Market Insights, Forecast to 2025
List of Tables and FiguresFigure Nuclear Medicine/Radiopharmaceutic Product Picture
Table Nuclear Medicine/Radiopharmaceutic Market Segments
Table Key Manufacturers Nuclear Medicine/Radiopharmaceutic Covered
Table Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product 2014-2025
Figure Diagnostic Product Picture
Table Major Manufacturers of Diagnostic
Figure Therapeutic Product Picture
Table Major Manufacturers of Therapeutic
Table Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by End User 2019-2025 (MT)
Figure Oncology
Figure Thyroid
Figure Cardiology
Figure Others
Figure Nuclear Medicine/Radiopharmaceutic Report Years Considered
Figure Global Nuclear Medicine/Radiopharmaceutic Market Size 2014-2025 (Million US$)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales 2014-2025 (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Regions 2014-2019 (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions 2014-2019
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions 2014-2019
Figure 2018 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions
Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions 2014-2019 (Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions 2014-2019
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions 2014-2019
Figure 2018 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers (2014-2019) (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers (2014-2019)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2014-2019) (Million USD)
Table Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2014-2019)
Figure Nuclear Medicine/Radiopharmaceutic Value Share by Manufacturers in 2018
Table Key Manufacturers Nuclear Medicine/Radiopharmaceutic Price (2014-2019) (USD/Kg)
Table Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Product (2014-2019) (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by Product (2014-2019)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product (2014-2019)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product in 2018
Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Product (2014-2019) (Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Product (2014-2019)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Product (2014-2019)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Product in 2018
Table Nuclear Medicine/Radiopharmaceutic Price by Product 2014-2019 (USD/Kg)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by End User (2014-2019) (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by End User (2014-2019)
Figure Global Sales Nuclear Medicine/Radiopharmaceutic Market Share by End User (2014-2019)
Figure Global Sales Nuclear Medicine/Radiopharmaceutic Market Share by End User in 2018
Figure North America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2014-2019 (MT)
Figure North America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2014-2019 (Million US$)
Table North America Nuclear Medicine/Radiopharmaceutic Sales by Countries (2014-2019) (MT)
Table North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2014-2019)
Figure 2018 North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries
Table North America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2014-2019) (Million US$)
Table North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure United States Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (MT)
Figure Canada Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Canada Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Mexico Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Table North America Nuclear Medicine/Radiopharmaceutic Sales by Product (2014-2019) (MT)
Table North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product (2014-2019)
Figure 2018 North America Nuclear Medicine/Radiopharmaceutic Market Share by Product
Table North America Nuclear Medicine/Radiopharmaceutic Sales by End User (2014-2019) (MT)
Table North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by End User (2014-2019)
Figure 2018 North America Nuclear Medicine/Radiopharmaceutic Market Share by End User
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2014-2019 (MT)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales by Countries (2014-2019) (MT)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries
Table Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2014-2019) (Million US$)
Table Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries
Figure Germany Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Germany Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure France Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure France Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure UK Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Italy Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Russia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales by Product (2014-2019) (MT)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product (2014-2019)
Figure 2018 Europe Nuclear Medicine/Radiopharmaceutic Market Share by Product
Table Europe Nuclear Medicine/Radiopharmaceutic Sales by End User (2014-2019) (MT)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by End User (2014-2019)
Figure 2018 Europe Nuclear Medicine/Radiopharmaceutic Market Share by End User
Figure Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Countries (2014-2019) (MT)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries
Figure China Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Korea Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure India Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure India Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Australia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Philippines Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Thailand Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Singapore Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Product (2014-2019) (MT)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Share by Product
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by End User (2014-2019) (MT)
Table Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Share by End User
Figure Central & South America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales by Countries (2014-2019) (MT)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries
Table Central & South America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries
Figure Brazil Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Brazil Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Argentina Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales by Product (2014-2019) (MT)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Nuclear Medicine/Radiopharmaceutic Market Share by Product
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales by End User (2014-2019) (MT)
Table Central & South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Nuclear Medicine/Radiopharmaceutic Market Share by End User
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries
Figure GCC Countries Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Turkey Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure Egypt Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2014-2019) (MT)
Figure South Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Product (2014-2019) (MT)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Share by Product
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by End User (2014-2019) (MT)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Share by End User
Table China Isotope Radiation Company Details
Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table China Isotope Radiation Recent Development
Table Dongcheng Company Details
Table Dongcheng Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Dongcheng Recent Development
Table Jaco Company Details
Table Jaco Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Jaco Recent Development
Table Ciaeriar Company Details
Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Ciaeriar Recent Development
Table Advanced Molecular-imaging Solution Company Details
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Advanced Molecular-imaging Solution Recent Development
Table Shanghai Atom Kexing Company Details
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Shanghai Atom Kexing Recent Development
Table Cardinal Health Company Details
Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Cardinal Health Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Mallinckrodt Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table GE Healthcare Recent Development
Table Lantheus Medical Imaging Company Details
Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Lantheus Medical Imaging Recent Development
Table Bayer Healthcare Company Details
Table Bracco Imaging Company Details
Table Eczacibasi-Monrol Nuclear Products Company Details
Table Nordion Company Details
Table Advanced Accelerator Applications Company Details
Table Iba Molecular Imaging Company Details
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions 2019-2025 (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Regions 2019-2025
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Regions 2019-2025
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Product 2019-2025 (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Product 2019-2025
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Product 2019-2025
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by End User 2019-2025 (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by End User 2019-2025
Figure North America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Nuclear Medicine/Radiopharmaceutic Value Chain
Table Nuclear Medicine/Radiopharmaceutic Customers List
Table Nuclear Medicine/Radiopharmaceutic Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Nuclear Medicine/Radiopharmaceutic Market Insights, Forecast to 2025
China Isotope RadiationDongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Cardinal Health
Mallinckrodt
GE Healthcare
Lantheus Medical Imaging
Bayer Healthcare
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
Iba Molecular Imaging
Request Sample
Request Discount
